Delgocitinib has emerged as a promising treatment for CHE, addressing unmet needs and enhancing understanding of this complex condition, notes Raj Chovatiya, MD, PhD, MSCI.

Dermatitis, a broad term for skin inflammation, encompasses various causes like irritants and allergens. Eczema, however, ...

A recent study suggests that people with eczema can bathe as often as they want — but moisturizing while skin is still damp ...

Eczema, a chronic skin condition causing itching and inflammation, affects people of all ages. It manifests in various forms like atopic dermatitis an ...

TENS of thousands of people in England suffering from debilitating eczema could soon be free of agonising symptoms after a ...

Chronic hand eczema is now considered a “common” skin disease in the United States, according to results from the CHECK study ...

A BBC health expert has shared a promising update on a new drug that has been approved for the treatment of eczema, a ...

If you’ve ever experienced eczema, or you know someone who has, you’re probably familiar with the physical effects of itchy, irritated skin. But the chronic condition can take a major mental toll, too ...

San Diego — Data from an open-label extension study of delgocitinib cream reflects the positive phase 3 safety and efficacy results released > 1 year ago from two separate trials in patients with ...

LEO Pharma has received Technology Appraisal Guidance (TAG) from the National Institute for Health and Care Excellence (NICE) for Anzupgo (delgocitinib) cream.

More than 62,000 people in England with debilitating hand eczema could benefit from a new treatment that has been given the ...